There were no statistically significant differences between galectin-1 (p = 0.1275), galectin-3 (p = 0.8060), or galectin-9 (p = 0.0794) levels and NSCLC stage (Figure 1), defined as stage I, II, III, and IV, as shown in Figure 1. This evidence concerns the gene LGALS3 and non-small cell lung carcinoma.